
Revvity Inc (RVTY) Stock Forecast & Price Target
Revvity Inc (RVTY) Analyst Ratings
Bulls say
Revvity is a global life sciences and diagnostics company with a unique portfolio that presents potential for margin expansion and growth in the Life Science Solutions segment despite industry challenges. However, future performance may be affected by competition and declining birth rates in the Reproductive Health business. The company's Signals platform and divestiture in the China ImmunoDx business are expected to drive growth, but there are concerns about meeting growth targets and potential risks. Overall, Revvity has a positive outlook with potential for growth but it may face challenges in meeting targets and navigating competition.
Bears say
Revvity is a global company with a diverse portfolio of products and services, but its sales are susceptible to currency and economic risks. Additionally, its reliance on funding from the highly volatile biopharmaceutical and academic sectors, combined with increasing competition and slower recovery in key markets, creates further challenges for sustained growth. The company's recent targeted acquisitions and divestitures may also pose risks by shifting its focus away from a potentially lucrative market, such as the rapidly aging and underpenetrated China autoimmune testing market. Overall, there may be limited self-help opportunities for the company, and its near-term prospects may not be as strong as initially projected, which could negatively affect its stock's performance.
This aggregate rating is based on analysts' research of Revvity Inc and is not a guaranteed prediction by Public.com or investment advice.
Revvity Inc (RVTY) Analyst Forecast & Price Prediction
Start investing in Revvity Inc (RVTY)
Order type
Buy in
Order amount
Est. shares
0 shares